IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells
- PMID: 9603455
- DOI: 10.1002/(SICI)1521-4141(199805)28:05<1507::AID-IMMU1507>3.0.CO;2-F
IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells
Abstract
NK T cells are an unusual T lymphocyte subset capable of promptly producing several cytokines after stimulation, in particular IL-4, thus suggesting their influence in Th2 lineage commitment. In this study we demonstrate that, according to the cytokines present in the microenvironment, NK T lymphocytes can preferentially produce either IL-4 or IFN-gamma. In agreement with our previous reports showing that their IL-4-producing capacity is strikingly dependent on IL-7, CD4-CD8-TCRalphabeta+ NK T lymphocytes, obtained after expansion with IL-1 plus granulocyte-macrophage colony-stimulating factor, produced almost undetectable amounts of IL-4 or IFN-gamma in response to TCR/CD3 cross-linking. However, the capacity of these T cells to produce IFN-gamma is strikingly enhanced when IL-12 is added either during their expansion or the anti-CD3 stimulation, while IL-4 secretion is always absent. A similar effect of IL-12 on IFN-gamma production was observed when NK T lymphocytes were obtained after expansion with IL-7. It is noteworthy that whatever cytokines are used for their expansion, IL-12 stimulation, in the absence of TCR/CD3 cross-linking, promotes consistent IFN-gamma secretion by NK T cells without detectable IL-4 production. Experiments in vivo demonstrated a significant upregulation of the capacity of NK T cells to produce IFN-gamma after anti-CD3 mAb injection when mice were previously treated with IL-12. In conclusion, we provide evidence that the functional capacities of NK T cells, which ultimately will determine their physiological roles, are strikingly dependent on the cytokines present in their microenvironment.
Similar articles
-
A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.J Immunol. 1999 Jul 1;163(1):93-101. J Immunol. 1999. PMID: 10384104
-
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.J Immunol. 1998 Oct 1;161(7):3400-7. J Immunol. 1998. PMID: 9759857
-
Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.J Immunol. 1999 May 1;162(9):5156-63. J Immunol. 1999. PMID: 10227987
-
Natural killer T cells: a potent cytokine-producing cell population.Eur Cytokine Netw. 1997 Sep;8(3):229-37. Eur Cytokine Netw. 1997. PMID: 9346354 Review.
-
Acute induction and priming for cytokine production in lymphocytes.Cytokine Growth Factor Rev. 1996 Aug;7(2):123-32. doi: 10.1016/1359-6101(96)00018-4. Cytokine Growth Factor Rev. 1996. PMID: 8899290 Review.
Cited by
-
The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.Clin Exp Immunol. 2006 Feb;143(2):194-202. doi: 10.1111/j.1365-2249.2005.02942.x. Clin Exp Immunol. 2006. PMID: 16412042 Free PMC article. Review.
-
Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.Front Microbiol. 2021 Dec 22;12:785662. doi: 10.3389/fmicb.2021.785662. eCollection 2021. Front Microbiol. 2021. PMID: 35003017 Free PMC article.
-
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.J Clin Invest. 2005 Nov;115(11):3093-103. doi: 10.1172/JCI25249. Epub 2005 Oct 13. J Clin Invest. 2005. PMID: 16224535 Free PMC article.
-
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.J Virol. 2002 May;76(9):4294-303. doi: 10.1128/jvi.76.9.4294-4303.2002. J Virol. 2002. PMID: 11932395 Free PMC article.
-
Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies.Front Immunol. 2020 Dec 17;11:607030. doi: 10.3389/fimmu.2020.607030. eCollection 2020. Front Immunol. 2020. PMID: 33391276 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials